Compare NEPH & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEPH | TOI |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.0M | 346.3M |
| IPO Year | 2004 | N/A |
| Metric | NEPH | TOI |
|---|---|---|
| Price | $4.93 | $3.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $6.00 | $6.00 |
| AVG Volume (30 Days) | 58.2K | ★ 1.6M |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | $17,930,000.00 | ★ $461,039,000.00 |
| Revenue This Year | $33.32 | $28.51 |
| Revenue Next Year | $12.27 | $23.54 |
| P/E Ratio | $35.51 | ★ N/A |
| Revenue Growth | ★ 32.36 | 21.67 |
| 52 Week Low | $1.39 | $0.21 |
| 52 Week High | $6.42 | $4.88 |
| Indicator | NEPH | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 48.86 | 54.74 |
| Support Level | $4.65 | $3.23 |
| Resistance Level | $5.34 | $3.90 |
| Average True Range (ATR) | 0.39 | 0.23 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 40.46 | 65.10 |
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.